Helix BioPharma Corp. Announces Grant and Cancellation of Stock Options

Executive Summary

• Helix BioPharma Corp. has granted 1,297,000 incentive stock options to directors, officers, employees, and consultants.
• The Company has cancelled an aggregate of 2,200,000 previously granted incentive stock options.

Key Details

• New Option Grant:
  • Quantity: 1,297,000 incentive stock options
  • Exercise Price: $1.63 per share
  • Term: Five years from the date of grant
  • Recipients: Directors, officers, employees, and consultants
• Option Cancellation:
  • Quantity Cancelled: 2,200,000 incentive stock options
  • Original Grant Date: July 19, 2024
  • Original Exercise Price: $1.10 per common share
  • Original Expiration Date: July 19, 2029